ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Donors, marginal"

  • 2022 American Transplant Congress

    The Feasibility of Changing HCC MELD Exception Criteria to an Exclusive DCD-Only Option: A Strategy to Increase DCD Utilization

    G. J. McKenna, P. Schultz, M. Finotti, M. Rosenzweig, A. Gupta, S. H. Lee, A. Wall, E. Martinez, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. Testa

    Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX

    *Purpose: Outcomes of DCD liver transplantation is comparable to DBD but routine utilization of DCD liver grafts is surprisingly uneven in the US. A more…
  • 2022 American Transplant Congress

    Cold Pulsatile Perfusion of Deceased Donor Kidneys Substantially Improves Kidney Utilization of Donors After Cardiac Death and Brain Dead Donors with KDPI Greater Than 60%

    D. S. Keith, E. Lessmann

    Kidney Transplant, Ascension Sacred Heart Hospital, Pensacola, FL

    *Purpose: To determine trends in usage of cold pulsatile kidney perfusion and its impact on organ utilization in the United States using the SRTR database.*Methods:…
  • 2022 American Transplant Congress

    An In Depth Assessment of Unsuccessful DCD Donor Procurement Attempts: Areas for Improvement

    M. Rosenzweig, M. Finotti, E. Martinez, S. Lee, A. Gupta, A. Wall, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. J. McKenna

    Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX

    *Purpose: DCD donors are a key way to expand allograft supply but an aggressive strategy of pursuing DCD liver allografts is associated with significant number…
  • 2022 American Transplant Congress

    Impact of Donor Quality on Outcomes for AKI and Non-AKI Kidneys with and without DGF

    C. Jadlowiec1, P. Budhiraja2, R. Butterfield1, M. Smith3, A. K. Mathur1, A. Moss1, H. Khamash2, K. Reddy1, R. Heilman2

    1Mayo Clinic Arizona, Phoenix, AZ, 2Division of Transplant Nephrology, Mayo Clinic Arizona, Phoenix, AZ, 3Division of Anatomic Pathology, Mayo Clinic Arizona, Phoenix, AZ

    *Purpose: The relevance of DGF, and whether it is clinically significant, continues to be debated. Our aim was to compare post-transplant outcomes between AKI and…
  • 2022 American Transplant Congress

    Impact of Recipient Warm Ischemic Time on Outcomes Associated with High KDPI and DCD Donor Kidneys: Cold Ischemic Time Remains Paramount

    M. L. Jacobs, R. Stratta, M. Garner, B. Sharda, A. Farney, G. Orlando, A. Reeves-Daniel, C. Jay

    Department of Surgery, Atrium Health Wake Forest Baptist, Winston Salem, NC

    *Purpose: Previously we demonstrated that cold ischemic time (CIT) beyond 24 hours was an important risk predictor of early graft loss (EGL) and primary non-function…
  • 2022 American Transplant Congress

    Distinct Phenotypes of Kidney Transplant Recipients with Delayed Graft Function Identified Through Machine Learning Consensus Clustering

    C. Jadlowiec1, C. Thongprayoon2, N. Leeaphorn3, W. Kaewput4, P. Pattharanitima5, M. Cooper6, W. Cheungpasitporn2

    1Division of Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ, 2Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, MN, 3Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO, 4Department of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand, 5Department of Internal Medicine, Thammasat University, Pathum Thani, Thailand, 6Medstar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC

    *Purpose: The significance of delayed graft function (DGF) and its impact on kidney transplant (KT) outcomes remains debated. We aimed to assess outcomes for KT…
  • 2022 American Transplant Congress

    Outcomes Following Renal Transplant with Hepatitis C Viremic Donors in an Elderly Veteran Population with Preemptive Mayvret Therapy

    R. Lopez-Soler1, A. Thorndyke1, C. Trotter1, A. Abadier2, M. Samra1

    1Surgery, Transplantation, Edward Hines Jr. Veterans Administration Hospital, Hines, IL, 2Surgery, Loyola University School of Medicine, Maywood, IL

    *Purpose: Overall mortality on the kidney transplant waiting list is higher for older diabetic patients. The average age of waitlisted veteran patients is 64, with…
  • 2022 American Transplant Congress

    Outcomes of Kidney Transplantation from a Male Donor with a Highly Elevated Prostate Specific Antigen Level (PSA) in Female Recipients

    S. K. Patel, E. Siskind, M. Jaleco, S. Shah, A. Adekile, S. Nijim, M. Laftavi

    Center for Transplantation, University Medical Center of Southern Nevada, Las Vegas, NV

    *Purpose: Donor derived malignancy is a contraindication for kidney transplantation. Published literature is devoid of instances of utilization of organs from donors with high PSA…
  • 2022 American Transplant Congress

    Quantification of Center Aggressiveness in Accepting Sub-Optimal Kidney Donations from Deceased Donors in the US

    T. P. Chiang1, M. Eagleson1, A. Massie1, M. Krach1, D. Segev1, J. Garonzik Wang2

    1Department of Surgery, Johns Hopkins University, Baltimore, MD, 2School of Medicine and Public Health, University of Wisconsin, Madison, WI

    *Purpose: Understanding center-level differences in usage of marginal deceased-donor kidneys (suboptimal kidneys, SOK) can help centers increase their deceased-donor transplant rate (DDKT), and to direct…
  • 2022 American Transplant Congress

    Predictors of Short and Long Term Outcomes of Donor After Cardiac Death (DCD) versus Donor After Brain Death (DBD) Kidney Transplantation from Supra Marginal Donors ( D4). A Machine Learning Analysis (MLA) of NHSBT Registry Data Since Year 2000

    H. Sharma1, A. Sharma2, T. Gunawardhane1, B. Devkaran1, K. Kapoor1, S. Mehra1

    1Royal Liverpool University Hospital, Liverpool, United Kingdom, 2Loyola University Chicago, Chicago, IL

    *Purpose: Marginal Donor 4- D4 ( Donor Risk Index ≥1.50 ) Matching was introduced as a part of new Kidney allocation scheme in the UK…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 29
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences